article · Structural Heart
Patients with cardiac amyloidosis undergoing aortic valve replacement present unique clinical challenges. While transcatheter aortic valve replacement (TAVR) is increasingly used in high-risk populations, data on outcomes compared to surgical aortic valve replacement (SAVR) in amyloidosis patients are limited. This study aimed to compare outcomes in amyloid patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.shj.2025.100608
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
